Virtual Rehabilitation in Parkinson Disease A Dopamine Transporter Imaging Study

被引:5
|
作者
Toldo, Juliana M. P. [1 ]
Arjona, Michelly [1 ]
Campos Neto, Guilherme C. [1 ]
Vitor, Taise [1 ]
Nogueira, Solange Amorim [1 ]
Amaro, Edson, Jr. [1 ]
Saba, Roberta A. [2 ,3 ]
Silva, Sonia M. C. A. [2 ,3 ]
Ferraz, Henrique B. [3 ]
Felicio, Andre C. [1 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[2] Inst Assistencia Med Servidor Publ Estadual Sao P, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Parkinson Disease; Virtual Rehabilitation; Dopamine Transporter; SPECT; TC-99M-TRODAT-1; SPECT; STRIATAL DOPAMINE; BALANCE; MOTOR; EXERCISE; ATTENTION; DEFICITS; REALITY; GAIT;
D O I
10.1097/PHM.0000000000001574
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective The aim of the study was to verify the effect of a virtual rehabilitation protocol for patients with Parkinson disease, primarily assessing striatal dopamine transporters and secondarily motor symptoms and quality of life. Design Nineteen patients with Parkinson disease underwent an 8-wk virtual rehabilitation protocol using XBOX 360S. Evaluation of dopamine transporters was performed by single-photon emission computed tomography using TRODAT-1 as the radioligand. Participants were clinically assessed using the Unified Parkinson Disease Rating Scale to quantify motor symptoms. Moreover, the Parkinson Disease Questionnaire and Short-Form Health Status Survey were used to assess quality of life and the Berg Balance Scale to assess balance. Results Regarding our primary outcome, dopamine transporter was significantly increased in the putamen contralateral to the clinically most affected body side (P = 0.034) considering preintervention and postintervention measurements. Furthermore, we observed significant improvement in Unified Parkinson Disease Rating Scale (10-point reduction, P = 0.001), Parkinson Disease Questionnaire (11.3-point reduction, P = 0.001), Short-Form Health Status Survey ("Functional capacity," P = 0.001; "Pain," P = 0.006; and "Mental Health" domains, P < 0.001), and Berg Balance Scale (5-point increase, P = 0.015). Conclusions In our group of Parkinson disease patients, this virtual rehabilitation protocol enabled a dopamine transporter increase in the region of the putamen contralateral to the clinically most affected body side. Moreover, motor signs and quality of life were significantly improved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 50 条
  • [31] Dopamine transporter imaging to predict the risk of aspiration in patients with Parkinson's disease (PD)
    Tanimura, J.
    Yamamoto, T.
    Shigemoto, Y.
    Sato, N.
    Takahashi, Y.
    MOVEMENT DISORDERS, 2024, 39 : S482 - S482
  • [33] Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease
    A. Lokkegaard
    L. M. Werdelin
    L. Regeur
    M. Karlsborg
    S. R. Jensen
    E. Brødsgaard
    F. F. Madsen
    M. N. Lonsdale
    L. Friberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 508 - 516
  • [34] No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson's disease
    Honkanen, E.
    Saari, L.
    Orte, K.
    Gardberg, M.
    Noponen, T.
    Joutsa, J.
    Kaasinen, V.
    MOVEMENT DISORDERS, 2019, 34 : S795 - S795
  • [35] No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson's disease
    Honkanen, Emma A.
    Saari, Laura
    Orte, Katri
    Gardberg, Maria
    Noponen, Tommi
    Joutsa, Juho
    Kaasinen, Valtteri
    MOVEMENT DISORDERS, 2019, 34 (10) : 1562 - 1566
  • [36] Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease
    Ravina, Bernard
    Marek, Kenneth
    Eberly, Shirley
    Oakes, David
    Kurlan, Roger
    Ascherio, Alberto
    Beal, Flint
    Beck, James
    Flagg, Emily
    Galpern, Wendy R.
    Harman, Jennifer
    Lang, Anthony E.
    Schwarzschild, Michael
    Tanner, Caroline
    Shoulson, Ira
    MOVEMENT DISORDERS, 2012, 27 (11) : 1392 - 1397
  • [37] Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease
    Marek, K
    Jennings, D
    Seibyl, J
    PARKINSON'S DISEASE, 2003, 91 : 183 - 191
  • [38] Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease
    Weintraub, D
    Newberg, AB
    Cary, MS
    Siderowf, AD
    Moberg, PJ
    Kleiner-Fisman, G
    Duda, JE
    Stern, MB
    Mozley, D
    Katz, IR
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (02) : 227 - 232
  • [39] Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson's disease
    Lokkegaard, A.
    Werdelin, L. M.
    Regeur, L.
    Karlsborg, M.
    Jensen, S. R.
    Brodsgaard, E.
    Madsen, F. F.
    Lonsdale, M. N.
    Friberg, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) : 508 - 516
  • [40] Assessment of outcomes in Parkinson's disease subjects randomized to SPECT imaging of the dopamine transporter
    Hickey, P. T.
    Kuchibhatla, M.
    Scott, B. L.
    Gauger, L.
    Stacy, M. A.
    MOVEMENT DISORDERS, 2015, 30 : S381 - S382